- Report
- May 2025
- 50 Pages
Global
From €2424EUR$2,650USD£2,063GBP
Aranidipine is a calcium channel blocker used to treat hypertension and angina pectoris. It is a member of the dihydropyridine class of calcium channel blockers, which are used to reduce blood pressure and improve blood flow to the heart. Aranidipine is also used to treat coronary artery disease, and is sometimes used in combination with other drugs to treat congestive heart failure. It is available in both oral and intravenous forms.
Aranidipine is a popular drug in the cardiovascular drug market, as it is effective in treating a variety of conditions. It is generally well-tolerated, with few side effects. It is also relatively inexpensive, making it an attractive option for many patients.
The Aranidipine market is highly competitive, with many companies offering their own versions of the drug. Some of the major players in the market include Pfizer, Novartis, Sanofi, Merck, and GlaxoSmithKline. Other companies, such as Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals, also offer generic versions of the drug. Show Less Read more